Poveda, A.

patient imatinib sarcoma cancer trabectedin tumor response study oncol treatment month phase stromal j clin oncol activity mutation therapy disease stromal tumors trial result retrospective analysis kinase translocation-related sarcomas antitumour activity resistance survival phase ii study oncology analysis retrospective tissue inhibitor imatinib mesylate / european journal cesne subtype mrc-l-sarcoma recist factor metastatic synovial sarcoma pharmacokinetic research clin cancer res cesne a.l bene fit antitumour synovial mesylate tyrosine criteria liposarcoma progression myxoid-round cell liposarcoma tissue sarcomas european tissue sarcoma demetri stromal tumor imatinib resistance level trs subtypes tumour translocation stromal tumours eur j cancer chemotherapy change response evaluation criteria research support fusion san filippo r metastatic gist disease control gist patients protein grade oncoprotein demetri gd